In accordance with the decreased v-FLIP expression, we demonstrated that ATO/Lena decreased phosphorylation of IκBα protein in both BC-3 and BCBL-1 ascites-derived cells at 48 h post treatment (Figure 3a). The gene discussed is NFKBIA; the disease is breast cancer.